Coronary artery calcium is associated with increased risk for lung and colorectal cancer in men and women: the Multi-Ethnic Study of Atherosclerosis (MESA).
Aged
Atherosclerosis
/ epidemiology
Calcium
Cardiovascular Diseases
/ epidemiology
Colorectal Neoplasms
/ complications
Coronary Artery Disease
/ complications
Coronary Vessels
Female
Humans
Lung
Male
Middle Aged
Prospective Studies
Risk Assessment
Risk Factors
Vascular Calcification
/ complications
cancer
cardiovascular disease
coronary arterial calcium
prevention
risk prediction
Journal
European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788
Informations de publication
Date de publication:
18 04 2022
18 04 2022
Historique:
received:
18
12
2020
accepted:
03
05
2021
pubmed:
5
6
2021
medline:
21
4
2022
entrez:
4
6
2021
Statut:
ppublish
Résumé
This study explored the association of coronary artery calcium (CAC) with incident cancer subtypes in the Multi-Ethnic Study of Atherosclerosis (MESA). CAC is an established predictor of cardiovascular disease (CVD), with emerging data also supporting independent predictive value for cancer. The association of CAC with risk for individual cancer subtypes is unknown. We included 6271 MESA participants, aged 45-84 and without known CVD or self-reported history of cancer. There were 777 incident cancer cases during mean follow-up of 12.9 ± 3.1 years. Lung and colorectal cancer (186 cases) were grouped based on their strong overlap with CVD risk profile; prostate (men) and ovarian, uterine, and breast cancer (women) were considered as sex-specific cancers (in total 250 cases). Incidence rates and Fine and Gray competing risks models were used to assess relative risk of cancer-specific outcomes stratified by CAC groups or Log(CAC+1). The mean age was 61.7 ± 10.2 years, 52.7% were women, and 36.5% were White. Overall, all-cause cancer incidence increased with CAC scores, with rates per 1000 person-years of 13.1 [95% confidence interval (CI): 11.7-14.7] for CAC = 0 and 35.8 (95% CI: 30.2-42.4) for CAC ≥400. Compared with CAC = 0, hazards for those with CAC ≥400 were increased for lung and colorectal cancer in men [subdistribution hazard ratio (SHR): 2.2 (95% CI: 1.1-4.7)] and women [SHR: 2.2 (95% CI: 1.0-4.6)], but not significantly for sex-specific cancers across sexes. CAC scores were associated with cancer risk in both sexes; however, this was stronger for lung and colorectal when compared with sex-specific cancers. Our data support potential synergistic use of CAC scores in the identification of both CVD and lung and colorectal cancer risk.
Identifiants
pubmed: 34086883
pii: 6292197
doi: 10.1093/ehjci/jeab099
pmc: PMC9016360
doi:
Substances chimiques
Calcium
SY7Q814VUP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
708-716Subventions
Organisme : NHLBI NIH HHS
ID : HHSN268201500003C
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95160
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95163
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001079
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95169
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95164
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95162
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95168
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95165
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95159
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95167
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000040
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95166
Pays : United States
Organisme : National Center for Advancing Translational Sciences (NCATS)
Organisme : NHLBI NIH HHS
ID : N01HC95161
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001420
Pays : United States
Organisme : NHLBI NIH HHS
ID : UL1-TR-000040
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500003I
Pays : United States
Informations de copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.
Références
Eur Heart J Cardiovasc Imaging. 2019 Apr 1;20(4):389-395
pubmed: 30590498
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):83-93
pubmed: 31005541
J Am Heart Assoc. 2017 Mar 20;6(3):
pubmed: 28320747
Ann Oncol. 2008 May;19(5):996-1002
pubmed: 18212091
Am J Prev Cardiol. 2020 Nov 21;4:100130
pubmed: 34327481
Atherosclerosis. 2017 Mar;258:119-130
pubmed: 28237909
Atherosclerosis. 2020 Feb;294:72-79
pubmed: 31784032
JACC Cardiovasc Imaging. 2016 May;9(5):568-576
pubmed: 26970999
Am J Epidemiol. 2009 Feb 15;169(4):444-54
pubmed: 19075250
Am J Med Sci. 2015 Jul;350(1):27-35
pubmed: 26110752
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2533-47
pubmed: 18086756
Am J Epidemiol. 2015 Jun 1;181(11):832-45
pubmed: 25888582
J Am Heart Assoc. 2020 Apr 21;9(8):e015306
pubmed: 32310025
J Am Coll Cardiol. 2020 Jun 2;75(21):2726-2737
pubmed: 32466889
CA Cancer J Clin. 2018 Nov;68(6):446-470
pubmed: 30303518
Prev Chronic Dis. 2016 Nov 17;13:E157
pubmed: 27854420
J Cardiovasc Comput Tomogr. 2014 Jan-Feb;8(1):26-32
pubmed: 24582040
Breast Cancer Res. 2003;5(5):239-47
pubmed: 12927032
JAMA. 2008 Dec 17;300(23):2765-78
pubmed: 19088354
J Am Heart Assoc. 2015 Nov 09;4(11):
pubmed: 26553214
Circulation. 2019 Feb 19;139(8):1110-1120
pubmed: 30779651
Circulation. 2016 Mar 15;133(11):1104-14
pubmed: 26976915
J Clin Oncol. 2017 Sep 1;35(25):2927-2933
pubmed: 28700275
Ann Intern Med. 2016 Feb 16;164(4):205-14
pubmed: 26756460
J Cardiovasc Comput Tomogr. 2020 Jan - Feb;14(1):12-17
pubmed: 30952612
Circ Cardiovasc Imaging. 2014 Mar;7(2):398-408; discussion 408
pubmed: 24642922
Carcinogenesis. 2000 Mar;21(3):427-33
pubmed: 10688862
Int J Cardiol. 2012 Mar 22;155(3):474-5
pubmed: 22243934
CA Cancer J Clin. 2018 Jan;68(1):31-54
pubmed: 29160902
Am J Med. 2020 Oct;133(10):e575-e583
pubmed: 32268145
Circulation. 2018 Feb 20;137(8):e30-e66
pubmed: 29437116
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):629-642
pubmed: 30944145
Atherosclerosis. 2006 Sep;188(1):112-9
pubmed: 16289071
Am J Epidemiol. 2002 Nov 1;156(9):871-81
pubmed: 12397006
Int J Cardiovasc Imaging. 2016 Mar;32(3):525-9
pubmed: 26515964
Prog Cardiovasc Dis. 2019 Sep - Oct;62(5):423-430
pubmed: 31715194
J Am Coll Cardiol. 1990 Mar 15;15(4):827-32
pubmed: 2407762
Circulation. 2010 Feb 2;121(4):586-613
pubmed: 20089546
Circ Res. 2011 Sep 2;109(6):687-96
pubmed: 21885836
Am J Clin Nutr. 2009 Sep;90(3):647-54
pubmed: 19625679
Atherosclerosis. 2021 Jan;316:79-83
pubmed: 33121743
Cardiol Res Pract. 2019 Jun 2;2019:7059806
pubmed: 31511792
Radiology. 2005 Jan;234(1):35-43
pubmed: 15618373
Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):648-56
pubmed: 26908437
JACC Cardiovasc Imaging. 2015 May;8(5):579-596
pubmed: 25937196